Description
Cp4G, an invaluable compound extensively used in the biomedical sector to study G protein-coupled receptors (GPCRs) is bestowed with unmatched affinity towards GPR120, a receptor that holds immense therapeutic promise to combat obesity and type 2 diabetes. Having demonstrated pronounced efficacy, Cp4G presents an exciting avenue for drug development in the fight against these rampant maladies